FT709

• CAT Number: I043837
• CAS Number: 2413991-74-7
• Molecular Formula: C23H22N4O7S
• Molecular Weight: 498.51
• Purity: ≥95%
• Synonyms: (2S)-1-[5-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-ylsulfonyl)-1,3,4,6-tetrahydropyrrolo[3,4-c]pyrrol-2-yl]-2-hydroxy-2-(2-methyl-1,3-benzoxazol-4-yl)ethanone
• InChI: InChI=1S/C23H22N4O7S/c1-13-25-20-17(3-2-4-18(20)34-13)21(28)23(29)26-9-14-11-27(12-15(14)10-26)35(30,31)16-7-19-22(24-8-16)33-6-5-32-19/h2-4,7-8,21,28H,5-6,9-12H2,1H3/t21-/m0/s1
• InChIKey: SCFWBZTVFCUBIZ-NRFANRHFSA-N
• SMILES: CC1=NC2=C(C=CC=C2O1)[C@@H](C(=O)N3CC4=C(C3)CN(C4)S(=O)(=O)C5=CC6=C(N=C5)OCCO6)O

FT709（Cat No.:I043837）is a small molecule inhibitor that selectively targets and modulates specific cellular pathways. It has shown potential in the treatment of diseases associated with dysregulated cellular processes, such as cancer and other proliferative disorders. FT709 is thought to interfere with the activity of enzymes or signaling networks that promote tumor growth, metastasis, or resistance to chemotherapy. Research is ongoing to evaluate its efficacy, safety, and potential as a therapeutic agent in oncology and other disease areas, with particular focus on its ability to enhance treatment outcomes and overcome drug resistance.